Woman walking outside with cane
Woman walking outside with cane
A ~20-30 second self-injection that can fit into my life—and my carry‑on.*

that’s living VYVIDLY™

The VYVGART Hytrulo prefilled syringe can go where you go. Self-inject once weekly wherever you can properly complete the injection—whether that’s at home or a hotel.

*Please see Patient Information. Follow appropriate administration steps and storage and handling guidance in the Instructions for Use. Monitor for signs and symptoms of an allergic reaction for at least 30 minutes after injection. If an allergic reaction occurs, you should seek medical attention.

Listen to this page

VYVGART Hytrulo can fit your life, not the other way around

One injection

It’s a single injection delivered under the skin (subcutaneously)—not into a vein.

One needle

Self-inject with the prefilled syringe that contains a single dose of VYVGART Hytrulo.

One time weekly

It’s your treatment routine—set the same day each week for your self-injection. If you miss an injection, you have a 3-day window to make it up before returning to your dosing schedule.

Person holding prefilled syringe Person holding prefilled syringe Person holding prefilled syringe
Need one more reason to consider the VYVGART Hytrulo prefilled syringe?

Did we mention you can self-inject in about 20-30 seconds?†

It can mean more time in your day for the people and things you love.

†Please see Patient Information. Follow appropriate administration steps in the Instructions for Use. Monitor for signs and symptoms of an allergic reaction for at least 30 minutes after injection. If an allergic reaction occurs, you should seek medical attention.

The people featured above are paid spokespeople taking VYVGART Hytrulo.
Not all patients respond to treatment. Talk to your doctor if you experience symptoms getting worse.
‡Please see Patient Information. Follow appropriate administration steps and storage and handling guidance in the Instructions for Use.

Personalized one-on-one training

You can self-inject, or a caregiver can do it for you. You can still get your injection from a healthcare professional.

You and/or your caregiver will receive in-person training at home or in your doctor’s office until you’re ready to inject on your own. You’ll also get a demonstration kit to help you practice.

In a study of people living with CIDP and caregivers:

100%

successfully used the prefilled syringe for self-injection using a practice pad and following the instructions (15 patients and 15 caregivers)§

§The study evaluated whether participants were able to successfully follow injection instructions, prepare the syringe, and inject it into a practice pad in a simulated-use environment.

Boost your confidence to self-inject

Watch this step-by-step demonstration to see how to use the VYVGART Hytrulo prefilled syringe. Then download the self-injection guide for extra support. Always reference the Instructions for Use for complete guidance.

Considerations when choosing a CIDP treatment

As you prep for your next doctor’s visit, use this chart to help learn about the different ways CIDP treatments can be given. This is an educational tool, not a comparison of effectiveness or safety for these treatments. The information listed for each treatment refers to an individual dose.

VYVGART Hytrulo prefilled syringe

Injection
(under the skin)

VYVGART Hytrulo viala

Injection
(under the skin)

IVIg

Infusion
(into a vein)

SCIg

Infusion
(under the skin)

a Comes in a vial and is given by a healthcare professional using a winged infusion set.

IV=intravenous; IVIg=intravenous immunoglobulin; SC=subcutaneous; SCIg=subcutaneous immunoglobulin. 

VYVGART Hytrulo prefilled syringe

About
20-30 seconds

VYVGART Hytrulo viala

About
30-90 seconds

IVIg

About
3-5 hours

SCIg

Up to
2 hours

a Comes in a vial and is given by a healthcare professional using a winged infusion set.
b Does not include preparation or monitoring time.
IV=intravenous; IVIg=intravenous immunoglobulin; SC=subcutaneous; SCIg=subcutaneous immunoglobulin. 

VYVGART Hytrulo prefilled syringe

Yesc

VYVGART Hytrulo viala

No
(given by healthcare professional only)

IVIg

No
(given by healthcare professional only)

SCIg

Yesc

a Comes in a vial and is given by a healthcare professional using a winged infusion set.
c Training required from a healthcare professional.
IV=intravenous; IVIg=intravenous immunoglobulin; SCIg=subcutaneous immunoglobulin.

VYVGART Hytrulo prefilled syringe

1
(injection)

VYVGART Hytrulo viala

1
(injection)

IVIg

1
(IV Infusion)

SCIg

1-8
(SC infusion)

a Comes in a vial and is given by a healthcare professional using a winged infusion set.
IV=intravenous; IVIg=intravenous immunoglobulin; SC=subcutaneous; SCIg=subcutaneous immunoglobulin. 

VYVGART Hytrulo prefilled syringe

Once weekly

VYVGART Hytrulo viala

Once weekly

IVIg

About once every 3‑6 weeks

SCIg

Treatments can be once weekly or once every 1‑4 weeks

a Comes in a vial and is given by a healthcare professional using a winged infusion set.
IV=intravenous; IVIg=intravenous immunoglobulin; SC=subcutaneous; SCIg=subcutaneous immunoglobulin. 

 VYVGART Hytrulo prefilled syringeVYVGART Hytrulo
viala		IVIgSCIg

How is it given?

Injection
(under the skin)

Injection
(under the skin)

Infusion
(into a vein)

Infusion
(under the skin)

How long
does it take?b

About
20-30
seconds

About
30-90
seconds

About
3-5
hours

Up to
2
hours

Can I do it myself?

Yesc

No
(given by healthcare professional only)

No
(given by healthcare professional only)

Yesc

How many injection or infusion sites are involved?

1
(injection)

1
(injection)

1
(IV infusion)

1-8
(SC infusion)

How frequently is it given?

Once
weekly

Once
weekly

About once every
3‑6 weeks

Treatments can be once weekly or once every 1‑4 weeks

a Comes in a vial and is given by a healthcare professional using a winged infusion set.
b Does not include preparation or monitoring time.
c Training required from a healthcare professional.
IV=intravenous; IVIg=intravenous immunoglobulin; SC=subcutaneous; SCIg=subcutaneous immunoglobulin.

Share your CIDP experience with your neurologist

The CIDP Doctor Discussion Guide can help you take note of your CIDP symptoms and abilities. Providing a better understanding of your daily life with CIDP may help your doctor determine if VYVGART Hytrulo is right for you.

GET YOUR GUIDE
My PRODUCT Y Path

Personalized support for every step of your VYVGART Hytrulo journey

After your doctor has prescribed you VYVGART Hytrulo, you can enroll in My VYVGART Path. Once enrolled, you’ll be paired with a Nurse Case Manager (NCM) for one-on-one support. If you’ll be self-injecting with the VYVGART Hytrulo prefilled syringe, an NCM can also provide additional education and resources on self-injection.

LEARN MORE

Learn more about VYVGART Hytrulo

VYVGART Hytrulo study results

Document with magnifying glass

See the safety and effectiveness results from the largest clinical study in CIDP history.

View the results

Cost and coverage

Hands holding a token

Find resources and information that may help you navigate your VYVGART Hytrulo treatment for CIDP.

Get resources
live VYVIDLY logo
live VYVIDLY logo

Have questions? Call 1‑833‑VYV‑CIDP (1‑833‑898‑2437) to speak with an educator about CIDP, how VYVGART Hytrulo works, study results, cost and coverage, and more.

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • hives
    • trouble breathing
    • low blood pressure
    • fainting
  • Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • hives
    • trouble breathing
    • low blood pressure
    • fainting
  • Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.

Questions? Call 1-833-VYV-CIDP
(1-833-898-2437)

This site is intended for patients and caregivers.

Disclaimer | Privacy Policy | Contact Us |

Patient and Prescribing Information
VYVGART Hytrulo Patient Information VYVGART Hytrulo Prescribing Information VYVGART Hytrulo Prefilled Syringe Instructions for Use

VYVGART and VYVGART Hytrulo are registered trademarks of argenx.

LIVE VYVIDLY and THAT’S LIVING VYVIDLY are trademarks of argenx.

For U.S. audiences only.

©2026 argenx 

US-VYV_HYT-26-00281 V1 10/2026

argenx logo